PMGC Holdings, formerly Elevai Labs (ELAB), announce the renaming of its wholly owned subsidiaries as part of a strategic effort to better align with the company’s evolving business focus as a diversified holding company. Effective immediately, the following name changes have taken place: Elevai Research is now PMGC Research; Elevai Biosciences is now Northstrive Biosciences.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELAB:
- Carmell Therapeutics enters definitive agreement to acquire Elevai Skincare
- Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada
- Elevai Labs subsidiary announces FDA regulatory pathway for EL-22
- Elevai Skincare launches S-Series Root Renewal System
- Elevai Labs subsidiary achieved record-breaking month in sales for 2024